原发性肝细胞癌在PET/CT显像中表现为68Ga-PSMA高摄取但18F-FDG低摄取
本文报道一例74岁男性新诊断肝细胞癌患者,在初始分期中接受18F-FDG PET/CT及68Ga-PSMA PET/CT。影像显示肝脏病灶18F-FDG摄取仅轻微,而68Ga-PSMA摄取强烈,全身未见转移灶。
要点
- 肝细胞癌可表达PSMA,68Ga-PSMA PET/CT可显示强烈摄取。
- 该例肝细胞癌病灶18F-FDG摄取仅轻微。
- 该例68Ga-PSMA PET/CT全身未见转移灶。
核心结论
- 本例原发性肝细胞癌在68Ga-PSMA PET/CT上呈强烈摄取,而18F-FDG摄取仅轻微,全身未见转移灶。
研究设计与样本
- 本文为个案报道,对象为一名74岁男性新诊断肝细胞癌患者,因初始分期接受18F-FDG PET/CT,并另行接受68Ga-PSMA PET/CT。
主要发现
- 18F-FDG PET/CT显示肝脏病灶仅轻微摄取。
- 68Ga-PSMA PET/CT显示肝脏病灶强烈摄取,全身未见转移灶。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ga-PSMA PET/CT imaging is an emerging imaging modality in prostate cancer. PSMA expression is also reported for nonprostate malignancies, including primary hepatocellular carcinoma. Herein, we present a case of a 74-year-ald man with recently diagnosed hepatocellular carcinoma who was referred for F-FDG PET/CT imaging for initial staging. The patient underwent F-FDG PET/CT as part of staging procedure; he also underwent Ga-PSMA PET/CT. PET/CT images revealed only slight F-FDG uptake in the liver lesion, but intense Ga-PSMA uptake, without any metastatic lesion seen elsewhere in the body.
引用
- Erhamamci S, Aslan N. Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging. Clin Nucl Med. 2020. PMID: 31977478. doi:10.1097/RLU.0000000000002922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。